Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension
Open Access
- 1 August 2016
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 28 (8) , 946-955
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation (PG/12/24/29476)
This publication has 37 references indexed in Scilit:
- An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL RegistryChest, 2012
- Characteristics and Outcome After Hospitalization for Acute Right Heart Failure in Patients With Pulmonary Arterial HypertensionCirculation: Heart Failure, 2011
- Sphingosine 1-phosphate (S1P)Neurology, 2011
- Prognostic factors of acute heart failure in patients with pulmonary arterial hypertensionEuropean Respiratory Journal, 2009
- Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-PhosphateScience, 2009
- Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic MiceCirculation, 2008
- Effect of Tryptophan Hydroxylase 1 Deficiency on the Development of Hypoxia-Induced Pulmonary HypertensionHypertension, 2007
- Essential Role for Sphingosine Kinases in Neural and Vascular DevelopmentMolecular and Cellular Biology, 2005
- Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720Journal of Biological Chemistry, 2004
- Cleavage of Automodified Poly(ADP-ribose) Polymerase during ApoptosisJournal of Biological Chemistry, 1999